Cargando…
Evaluating the longitudinal effectiveness of preventive measures against COVID-19 and seroprevalence of IgG antibodies to SARS-CoV-2 in cancer outpatients and healthcare workers
BACKGROUND: It has been assumed that cancer patients, especially those undergoing chemotherapy, are at increased risk for infection and severe illness from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) compared to the general population. After the first alert message from the local he...
Autores principales: | Fong, Dominic, San Nicolò, Katja Olga, Alber, Monika, Mitterer, Manfred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838655/ https://www.ncbi.nlm.nih.gov/pubmed/33502609 http://dx.doi.org/10.1007/s00508-020-01807-6 |
Ejemplares similares
-
Seroprevalence of SARS-CoV-2 IgG among healthcare workers in Lagos, Nigeria
por: Ige, Fehintola Anthonia, et al.
Publicado: (2023) -
High levels of anti–SARS-CoV-2 IgG antibodies in previously infected patients with cancer after a single dose of BNT 162b2 vaccine
por: Fong, Dominic, et al.
Publicado: (2021) -
Ebola Virus IgG Seroprevalence in Southern Mali
por: Bane, Sidy, et al.
Publicado: (2021) -
The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19
por: Qin, Xuzhen, et al.
Publicado: (2021) -
SARS-CoV2 IgG antibody: Seroprevalence among health care workers
por: Prakash, Om, et al.
Publicado: (2021)